← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Immport Therapeutics, Inc.
Irvine, CA
$17,215,171
Total funding
25
Grants
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,972,171 · 24
CDC$243,000 · 1
By mechanism
R43$7,790,062 · 18
R44$5,333,268 · 2
R42$1,847,306 · 1
R41$1,594,285 · 2
R21$350,250 · 1
N43$300,000 · 1
Investigators at Immport Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Seriodiagnostic arrays for biodefense and emerging infectious diseases$1,000,000
R44 · FY2008 · AI
Seriodiagnostic arrays for biodefense and emerging infectious diseases$1,000,000
R44 · FY2009 · AI
Seriodiagnostic arrays for biodefense and emerging infectious diseases$991,855
R44 · FY2010 · AI
Scanning Chlamydia proteome for vaccine antigens$973,681
R42 · FY2009 · AI
Scanning Chlamydia proteome for vaccine antigens$873,625
R42 · FY2010 · AI
Protective biomarkers for the development of vaccines against malaria$781,909
R44 · FY2012 · AI
Protective biomarkers for the development of vaccines against malaria$780,873
R44 · FY2013 · AI
Protective biomarkers for the development of vaccines against malaria$778,631
R44 · FY2014 · AI
Development of a multiplex serodiagnostic assay for B burgdorferi infection$525,836
R43 · FY2007 · AI
Vaccinia Proteome Affinity Reagents From Phage Display$497,889
R41 · FY2005 · AI
Vaccinia Proteome Affinity Reagents From Phage Display$497,141
R41 · FY2004 · AI
Adjuvants for Agile Vaccine Development$446,351
R43 · FY2006 · AI
Adjuvants for Agile Vaccine Development$440,494
R43 · FY2005 · AI
Scanning the P. falciparum proteome for vaccine antigens$300,389
R43 · FY2006 · AI
Scanning the Cryptosporidium proteome for vaccine antigens$300,000
R43 · FY2020 · AI
Antibodies to malaria blood stages in mixed-species infections$300,000
R43 · FY2008 · AI
Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis$300,000
R43 · FY2021 · AI
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics$300,000
R43 · FY2012 · AI
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics$300,000
R43 · FY2013 · AI
SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections$300,000
N43 · FY2024 · AI